Avation Medical

Series-B+
avation.com Biotech & Healthcare
Total Funding $22M
Latest Round Undisclosed Series-B+
Last Announced Mar 20, 2026
Investors Undisclosed
Decision Makers 6 Verified

About Avation Medical

Vivally® is the only FDA-cleared wearable neuromodulation system for overactive bladder. Treat OAB at home in just 30 minutes, 3 times per week.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Undisclosed
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website avation.com
Domain Registered Date Mar 8, 1999

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Series-B+ announced

    fundraisingfox.com

  2. Capital Raise

    Raised $22,000,000 · Series-B+

    PR Newswire

  3. Milestone

    Website domain registered

    avation.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Avation Medical.

Funding History

2 Rounds
Series-B+ · Mar 20, 2026
Series-B+ · Feb 1, 2024
$22,000,000 PR Newswire

Founders & Leadership

1

Manish Vaishya

Chief Executive Officer, Co-Founder & Board Member

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts